Signant Helps Sponsors Deliver COVID-19 Vaccines

Signant’s clinical research technology solutions and services improve coronavirus vaccine studies to faciliate the development of new vaccines.

Get details on how Signant helps improve study success in these ways:

• Simplify clinical outcome assessments with built-in electronic reactogenicity diary
• Conduct large scale studies
• Improve engagement in long term follow up periods
• Manage data for adaptive trial designs

Look inside for our coronavirus vaccine study experience and therapeutic area experts.